Results 61 to 70 of about 2,997,094 (204)
Vulvar cancer patients' quality of life: A qualitative assessment
To develop a vulvar cancer-specific quality of life (QOL) subscale to accompany the Functional Assessment of Cancer–General (FACT-G) questionnaire, semistructured interviews were performed with 15 patients treated for vulvar cancer (FIGO stage 0–3).
Trimmel, M. +9 more
core +1 more source
Atrophic vulvar lichen sclerosus evolving to an epidermoid carcinoma: about an uncommon case
Malignant tumors of the vulva are usually budding, ulcerated, or infiltrating. The fear of cancer must always be in mind, in front of any vulvar lesion.
Abderrahim Siati +4 more
doaj +1 more source
In 120 patients receiving postmastectomy radiotherapy, each irradiated chest wall was divided into medial and lateral halves, which were randomised to Mepitel Film or StrataXRT. Mepitel Film reduced grade 2–3 acute radiation dermatitis and clinician‐assessed erythema and moist desquamation over time.
Shing Fung Lee +6 more
wiley +1 more source
Diabetes mellitus and the risk of vulvar and vaginal cancer: results from a large cohort study
Background Although diabetes mellitus has been associated with increased risk of several cancers, evidence in relation to vulvar and vaginal cancers has been limited and inconsistent.
Dagfinn Aune +7 more
doaj +1 more source
Vulvar cancer in Tunisia: Epidemiological and clinicopathological features multicentric study
Objective: To describe for the first time the epidemiologic and clinico-pathologic characteristics of vulvar cancer in Tunisia. Design: Two parts are distinguished in this study: Part1: Multicentric retrospective study about the characteristics of all ...
Mehdi Kehila, MD +12 more
doaj +1 more source
Plasma Cell Mucositis: A 20‐Year Retrospective Review at a Tertiary Center
ABSTRACT Background Plasma cell mucositis (PCM) is a rare, chronic inflammatory condition of mucosal surfaces that is likely underdiagnosed and underreported, with limited data on its clinical characteristics, extracavitary involvement, and treatment outcomes.
Miguel A. Aristizabal‐Torres +4 more
wiley +1 more source
Prognostic factors in patients with vulvar cancer: the VULCAN study
Objective: This study aimed to analyze the prognostic factors for overall and progression-free survival in patients with vulvar cancer. Methods: This international, multicenter, retrospective study included 2453 patients diagnosed with vulvar cancer at ...
Zapardiel, Ignacio +2 more
core +1 more source
WNL we never looked: vulvar carcinoma incidence after screening cutoff
The incidence of vulvar carcinoma increases with age, though elderly women receive less aggressive cancer therapies and fewer strategies aimed at cancer prevention.
Amaris N. Geisler, MD, Jodi E. Ganz, MD
doaj +1 more source
Risk of Cancer With Hormone Replacement Therapy: A Narrative Review
ABSTRACT Hormone replacement therapy (HRT) remains the cornerstone of menopausal symptom management, effectively alleviating vasomotor symptoms and genitourinary syndrome, whilst mitigating long‐term risks such as osteoporosis. However, despite an increasing body of evidence on the relative safety of HRT, earlier studies that demonstrated an increased ...
Gabriella Yongue +3 more
wiley +1 more source
Vulvar cancer is a malignancy of female lower genital tract with incidence of 1:100,000 in Poland. The most common types of vulvar cancers are squamous cell carcinoma and basal cell carcinoma.
Michał Migda +3 more
doaj +1 more source

